The Patent Finder
US

1,2,4-Oxadiazole Derivatives as Immunomodulators

US 10,173,989 In force
OverviewFamilyAssignmentsSources & methods

Term ends Sep 5, 2034 · High confidence

Filed Sep 24, 2017 as application 15/713,671 · Granted Jan 8, 2019
Base term, 20 years from filing
Today
20 years from filing
2014 2034
Clock starts
Sep 5, 2014
Term ends
Sep 5, 2034
Granted
Jan 8, 2019
base term fee events Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 5, 2014, when application 14/478,759, the earliest non-provisional in its chain, was filed (this one was filed Sep 24, 2017)Sep 5, 2034High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderSep 5, 2034High confidence

This family

Application 14/478,759Abandoned
not computed
not computed
US 9,771,338In force
Sep 2034
Sep 2034
US 10,173,989this patent
Sep 2034
Sep 2034
US 10,590,093In force
Sep 2034
Sep 2034
US 10,961,205In force
Sep 2034
Sep 2034
US 11,512,060In force
Sep 2034
Sep 2034
US 12,037,321In force
no later than Sep 2034
no later than Sep 2034
US 12,643,870In force
Sep 2034
Sep 2034
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 16, 2023
Reel 63654, frame 411
Aurigene Discovery Technologies LimitedAurigene Oncology LimitedChange of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited